Frontiers in Oncology | Breast Cancer

Original Research

Published on 07 Jul 2023

HER2-low metastases of HER2-negative primary tumors: a single institution analysis of intertumoral and internodal heterogeneity in node-positive breast cancer

in Breast Cancer

Ulrika Pellas
Annette Bauer
Ilija Vladimir Baroš
Caterina Fattorini
Tibor Tot

Frontiers in Oncology

doi 10.3389/fonc.2023.1167567

2,180 views
4 citations

Original Research

Published on 07 Jul 2023

RNA atlas and competing endogenous RNA regulation in tissue-derived exosomes from luminal B and triple-negative breast cancer patients

in Breast Cancer

Ji Wang
Xianyu Zhang
Zilong You
Yuhuan Meng
Xijie Fan
Guangdong Qiao
Da Pang

Frontiers in Oncology

doi 10.3389/fonc.2023.1113115

2,377 views
3 citations

Original Research

Published on 06 Jul 2023

Impact of AKT1 on cell invasion and radiosensitivity in a triple negative breast cancer cell line developing brain metastasis

in Breast Cancer

Joanna Kempska
Leticia Oliveira-Ferrer
Astrid Grottke
Minyue Qi
Malik Alawi
Felix Meyer
Kerstin Borgmann
Fabienne Hamester
Kathrin Eylmann
Maila Rossberg

Frontiers in Oncology

doi 10.3389/fonc.2023.1129682

4,469 views
4 citations

Original Research

Published on 06 Jul 2023

Diagnostic value of Kaiser score combined with breast vascular assessment from breast MRI for the characterization of breast lesions

in Breast Cancer

Xin-zhu Zhou
Lian-hua Liu
Shuang He
Hui-fang Yao
Li-ping Chen
Chen Deng
Shuang-Ling Li
Xiao-yong Zhang
Hua Lai

Frontiers in Oncology

doi 10.3389/fonc.2023.1165405

2,000 views
2 citations

Original Research

Published on 04 Jul 2023

The effect of the alpha-specific PI3K inhibitor alpelisib combined with anti-HER2 therapy in HER2+/PIK3CA mutant breast cancer

in Breast Cancer

Maria Letizia Cataldo
Pietro De Placido
Daniela Esposito
Luigi Formisano
Grazia Arpino
Mario Giuliano
Roberto Bianco
Carmine De Angelis
Bianca Maria Veneziani

Frontiers in Oncology

doi 10.3389/fonc.2023.1108242

5,086 views
8 citations

Original Research

Published on 04 Jul 2023

Predicting the immune microenvironment and prognosis with a anoikis - related signature in breast cancer

in Breast Cancer

Xiuqing Lu
Qi Yuan
Chao Zhang
Sifen Wang
Weidong Wei

Frontiers in Oncology

doi 10.3389/fonc.2023.1149193

3,408 views
5 citations

Original Research

Published on 04 Jul 2023

Potential risk of tamoxifen: gut microbiota and inflammation in mice with breast cancer

in Breast Cancer

Hailong Li
Xiufei Gao
Yian Chen
Mengqian Wang
Chuchu Xu
Qinghong Yu
Ying Jin
Jiaqing Song
Qi Zhu

Frontiers in Oncology

doi 10.3389/fonc.2023.1121471

7,881 views
8 citations

Systematic Review

Published on 30 Jun 2023

Meta-analysis of effects of yoga exercise intervention on sleep quality in breast cancer patients

in Breast Cancer

Jingzhi Zhu
Xiaojuan Chen
Xinxian Zhen
Huan Zheng
Hong Chen
Huimin Chen
Huizhao Liao
Jinru Zhu
Chaoyu Wang
Zhenzhen Zheng

Frontiers in Oncology

doi 10.3389/fonc.2023.1146433

4,739 views
11 citations

Original Research

Published on 29 Jun 2023

CTSL, a prognostic marker of breast cancer, that promotes proliferation, migration, and invasion in cells in triple-negative breast cancer

in Breast Cancer

Lianmei Zhang
Yang Zhao
Jing Yang
Yaning Zhu
Ting Li
Xiaoyan Liu
Pengfei Zhang
Jingliang Cheng
Suan Sun
Chunli Wei

Frontiers in Oncology

doi 10.3389/fonc.2023.1158087

2,655 views
7 citations

Original Research

Published on 29 Jun 2023

Quality of life and wellbeing among breast cancer patients in Lahore, Pakistan

in Breast Cancer

Fiza Ayub
Tahir Mehmood Khan
Mirza Rafi Baig
Muhammad Usman Amin
Humera Tahir

Frontiers in Oncology

doi 10.3389/fonc.2023.1105411

4,424 views
3 citations

Original Research

Published on 28 Jun 2023

Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey

in Breast Cancer

Çağlar Ünal
Tolga Özmen
Çetin Ordu
Kezban Nur Pilanci
Ahmet Serkan İlgün
Erhan Gökmen
Elvina Almuradova
Mustafa Özdoğan
Nilüfer Güler
Cihan Uras

Frontiers in Oncology

doi 10.3389/fonc.2023.1151733

21,551 views
5 citations

Original Research

Published on 27 Jun 2023

Pan-cancer evaluation of clinical value of mitotic network activity index (MNAI) and its predictive value for immunotherapy

in Breast Cancer

Xuanyu Mao
Yimeng Cai
Sarah Long
Jesus Perez-Losada
Jian-Hua Mao
Hang Chang

Frontiers in Oncology

doi 10.3389/fonc.2023.1178568

3,544 views
1 citation

Original Research

Published on 27 Jun 2023

Discrepancies in breast cancer’s oncological outcomes between public and private institutions in the southeast region of Brazil: a retrospective cohort study

in Breast Cancer

Diocésio Alves Pinto Andrade
Ana Carolina Veneziani
Carlos Eduardo Paiva
Ricardo dos Reis
Carlos Alberto Fruet Filho
André Octávio Nicolau Sanches
Alison Wagner Azevedo Barroso
Alessandra Caroline Moretto Carbinatto Paz
Georgia Cristina de Mello Kons
Daniel D’Almeida Preto

Frontiers in Oncology

doi 10.3389/fonc.2023.1169982

2,768 views
1 citation

Original Research

Published on 27 Jun 2023

Pathologic response and survival after neoadjuvant chemotherapy with or without pertuzumab in patients with HER2-positive breast cancer: the Neopearl nationwide collaborative study

in Breast Cancer

Agnese Fabbri
Fabrizio Nelli
Andrea Botticelli
Diana Giannarelli
Eleonora Marrucci
Cristina Fiore
Antonella Virtuoso
Simone Scagnoli
Simona Pisegna
Daniele Alesini

Frontiers in Oncology

doi 10.3389/fonc.2023.1177681

3,405 views
2 citations

Case Report

Published on 26 Jun 2023

Breast mass as the first sign of metastasis from rectal carcinoma: a case report and review of the literature

in Breast Cancer

Jiawei Xu
Chao Liu
Chengdong Yu
Tenghua Yu
Fan Fan
Xiaofang Zhang
Chuansheng Huang
Wen Chen
Zhengkui Sun
Meng Zhou

Frontiers in Oncology

doi 10.3389/fonc.2023.1211645

2,587 views
2 citations

Original Research

Published on 23 Jun 2023

Interleukin 17 in early invasive breast cancer

in Breast Cancer

Marina Popović
Natalija Dedić Plavetić
Damir Vrbanec
Zlatko Marušić
Davor Mijatović
Ana Kulić

Frontiers in Oncology

doi 10.3389/fonc.2023.1171254

2,740 views
6 citations

Navigation group

Articles

HER2-low metastases of HER2-negative primary tumors: a single institution analysis of intertumoral and internodal heterogeneity in node-positive breast cancer

RNA atlas and competing endogenous RNA regulation in tissue-derived exosomes from luminal B and triple-negative breast cancer patients

Impact of AKT1 on cell invasion and radiosensitivity in a triple negative breast cancer cell line developing brain metastasis

Diagnostic value of Kaiser score combined with breast vascular assessment from breast MRI for the characterization of breast lesions

The effect of the alpha-specific PI3K inhibitor alpelisib combined with anti-HER2 therapy in HER2+/PIK3CA mutant breast cancer

Predicting the immune microenvironment and prognosis with a anoikis - related signature in breast cancer

Potential risk of tamoxifen: gut microbiota and inflammation in mice with breast cancer

Meta-analysis of effects of yoga exercise intervention on sleep quality in breast cancer patients

CTSL, a prognostic marker of breast cancer, that promotes proliferation, migration, and invasion in cells in triple-negative breast cancer

Quality of life and wellbeing among breast cancer patients in Lahore, Pakistan

Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey

Pan-cancer evaluation of clinical value of mitotic network activity index (MNAI) and its predictive value for immunotherapy

Discrepancies in breast cancer’s oncological outcomes between public and private institutions in the southeast region of Brazil: a retrospective cohort study

Pathologic response and survival after neoadjuvant chemotherapy with or without pertuzumab in patients with HER2-positive breast cancer: the Neopearl nationwide collaborative study

Breast mass as the first sign of metastasis from rectal carcinoma: a case report and review of the literature

Interleukin 17 in early invasive breast cancer